Taysha Gene Therapies Inc
TSHA
Insider trades and stock quote 2024-2026
All insider trades at Taysha Gene Therapies Inc
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/10/2026
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$6.2 |
$1,248,000 |
|
4/10/2026
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$4.5 |
$892,000 |
|
2/4/2026
|
Sell |
Alam, Kamran |
CHIEF FINANCIAL OFFICER |
$4.5 |
$7,481 |
|
1/26/2026
|
Sell |
Nolan, Sean P. |
Chief Executive Officer |
$4.6 |
$190,448 |
|
1/26/2026
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$4.6 |
$124,092 |
|
1/26/2026
|
Sell |
Alam, Kamran |
CHIEF FINANCIAL OFFICER |
$4.6 |
$109,944 |
|
1/23/2026
|
Sell |
Nolan, Sean P. |
Chief Executive Officer |
$4.8 |
$649,748 |
|
1/23/2026
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$4.8 |
$423,377 |
|
1/23/2026
|
Sell |
Alam, Kamran |
CHIEF FINANCIAL OFFICER |
$4.8 |
$375,098 |
|
1/12/2026
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$4.7 |
$942,000 |
|
12/1/2025
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$4.5 |
$1,172,812 |
|
11/28/2025
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$4.8 |
$523,094 |
|
9/10/2025
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$3.2 |
$646,000 |
|
8/21/2025
|
Sell |
Alam, Kamran |
CHIEF FINANCIAL OFFICER |
$2.8 |
$155,299 |
|
8/21/2025
|
Sell |
Nagendran, Sukumar |
President and Head of R&D |
$2.8 |
$162,604 |
|
5/30/2025
|
Buy |
Manning, Paul B. |
Ten Percent Owner |
$2.8 |
$2,062,500 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now